Lunai Bioworks Inc. (LNAI) — 10-Q Filings
All 10-Q filings from Lunai Bioworks Inc.. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (5)
-
Lunai Bioworks Swings to Profit on Subsidiary Bankruptcy Gain, Faces Going Concern Doubt
— Nov 14, 2025 Risk: high
Lunai Bioworks Inc. (LNAI) reported a net income of $2,819,021 for the three months ended September 30, 2025, a significant improvement from a net loss of $44,2 -
Renovaro Inc. Files 10-Q for Q3 2025
— May 15, 2025 Risk: medium
Renovaro Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Enochian Biosciences Inc. and Renovaro Biosciences Inc., is in -
Renovaro Inc. Files Q3 2024 10-Q Report
— Nov 14, 2024 Risk: medium
Renovaro Inc. filed its quarterly report for the period ending September 30, 2024. The company, previously known as Enochian Biosciences Inc., is involved in th -
Renovaro Inc. Files Q3 2024 10-Q
— May 15, 2024 Risk: medium
Renovaro Inc. filed its quarterly report for the period ending March 31, 2024. The company, previously known as Enochian Biosciences Inc. and Renovaro Bioscienc -
Renovaro Inc. Files 10-Q for Period Ending December 31, 2023
— Feb 14, 2024 Risk: low
RENOVARO INC. (LNAI) filed a Quarterly Report (10-Q) with the SEC on February 14, 2024. Renovaro Inc. (formerly Enochian Biosciences Inc.) filed a 10-Q report f
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX